XML 39 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 9 - Sale of Common Stock (Details) (USD $)
1 Months Ended 3 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended 3 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 3 Months Ended
Feb. 22, 2013
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Sep. 18, 2013
September 2013 SPA [Member]
Warrant Issued For Placement Agent Services [Member]
Sep. 18, 2013
September 2013 SPA [Member]
September 2013 Warrants [Member]
Sep. 18, 2013
September 2013 SPA [Member]
Dec. 31, 2013
September 2013 SPA [Member]
Feb. 22, 2013
February 2013 SPA [Member]
Warrant Issued For Placement Agent Services [Member]
Feb. 22, 2013
February 2013 SPA [Member]
February 2013 Warrants [Member]
Feb. 22, 2013
February 2013 SPA [Member]
Mar. 31, 2014
February 2013 SPA [Member]
Feb. 22, 2013
Additional Issurance Due To Anti-Dilutive Provisions [Member]
Mar. 31, 2014
February 2013 SPA Option [Member]
Mar. 31, 2014
September 2013 Warrants [Member]
Dec. 31, 2013
September 2013 Warrants [Member]
Mar. 31, 2014
September 2013 SPA Option [Member]
Sep. 18, 2013
February 2013 Warrants [Member]
Mar. 31, 2014
February 2013 Warrants [Member]
Mar. 31, 2013
February 2013 Warrants [Member]
Dec. 31, 2013
February 2013 Warrants [Member]
Mar. 31, 2013
February 2013 SPA Option [Member]
Note 9 - Sale of Common Stock (Details) [Line Items]                                            
Stock Issued During Period, Shares, New Issues (in Shares)             29,166,668       26,933,333   40,400,001                  
Sale of Stock, Price Per Share (in Dollars per share)             $ 0.06       $ 0.15                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)         1,485,333 30,625,001 29,166,668   1,885,333 28,818,666 26,933,333                      
Proceeds from Issuance or Sale of Equity             $ 1,750,000       $ 4,040,000                      
Proceeds from Issuance or Sale of Equity, Net             1,575,000       3,504,000                      
Term To Hold Share Purchase             24 months       24 months                      
(in Shares)             16,666,667       7,000,000                      
Right To Purchase Common Stock Shares (in Shares)             16,666,667       7,000,000                      
Delivery Period for Common Shares Upon Investors' Request             3 days       3 days                      
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)   35,666,000 35,666,000         16,666,667       19,000,000                    
Percentage of Common Shares Available for Purchase at Initial Closing             50.00%       50.00%                      
Class of Warrant or Right Exercise Period of Warrants or Rights           5 years         5 years                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)           0.08       0.20         0.08 0.08     0.08   0.08  
Class of Warrant or Right Period for Presenting Effective Registration Statement for Avoiding Cashless Exercise of Warrants or Rights           180 days       180 days                        
Limitation of Beneficially Owned Percentage of Common Stock for Exercise of Warrants           4.99%       4.99%                        
Discretionary Increase in Limitation of Beneficially Owned Percentage of Common Stock for Exercise of Warrants           9.99%       9.99%                        
Notice Period for Discretionary Increase in Limitation of Beneficially Owned Percentage of Common Stock for Exercise of Warrants           61 days       61 days                        
Warrants Grant Date Fair Value                           1,211,000 1,807,000   1,166,000   2,759,000      
Derivative Liability, Fair Value, Gross Liability                             842,000   351,000   1,981,000      
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings   179,000                         215,000   59,000   540,000 884,000   583,000
(in Shares)                                   43,228,001        
(in Dollars per share)                                   $ 0.08        
Net Proceeds Used For Investor Relations   1,000,000                                        
Payments For Investor Relations 500,000   220,000 250,000                                    
Restricted Cash and Cash Equivalents, Current   $ 30,000 $ 30,000